CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY
1 total filings · 0 classes · Active since Apr 2026
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 37/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 14, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99777553 | CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY | Apr 21, 2026 | Registered | 005 Pharmaceuticals 042 Science & Technology 044 Medical & Beauty Services | Seqirus Inc. |
Weekly visibility reports showing how ChatGPT mentions CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark portfolio
What trademarks does CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY hold?
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals), Class 42 (Science & Technology), Class 44 (Medical & Beauty Services). The most recent filings are registered to Seqirus Inc..
How many trademarks does CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY. The brand has been actively filing since April 2026. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY file most often?
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark?
The most recent filings under the CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY mark are registered to Seqirus Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY expanding into new categories?
The current WikiTrademarks Expansion Score for CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY is 37 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY trademark filings?
Click the Watch Brand button at the top of this page to add CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY to another owner · Browse all NICE classes · Most valuable brands